105 related articles for article (PubMed ID: 8549347)
1. Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400mg.
Garraffo R; Drugeon HB
Drugs; 1995; 49 Suppl 2():317-20. PubMed ID: 8549347
[No Abstract] [Full Text] [Related]
2. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin.
Naber KG; Theuretzbacher U; Moneva-Koucheva G; Stass H
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia.
Saengsuwan P; Jaruratanasirikul S; Jullangkoon M; Aeinlang N
J Med Assoc Thai; 2010 Jul; 93(7):784-8. PubMed ID: 20649056
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
[TBL] [Abstract][Full Text] [Related]
5. Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration.
Gebru E; Lee JS; Chang ZQ; Hwang MH; Cheng H; Park SC
Antimicrob Agents Chemother; 2009 Jul; 53(7):3024-9. PubMed ID: 19398644
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
Albarellos GA; Kreil VE; Landoni MF
J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis.
Mikamo H; Ninomiya M; Tamaya T
J Infect Chemother; 2003 Sep; 9(3):276-7. PubMed ID: 14513401
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg.
Szałek E; Tomczak H; Kamińska A; Grabowski T; Smuszkiewicz P; Matysiak K; Wolc A; Kaczmarek Z; Grześkowiak E
Adv Med Sci; 2012; 57(2):217-23. PubMed ID: 22968336
[TBL] [Abstract][Full Text] [Related]
9. Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
Dan M; Poch F; Quassem C; Kitzes R
Antimicrob Agents Chemother; 1994 Apr; 38(4):837-41. PubMed ID: 8031055
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle.
Elias G; Lee JS; Hwang MH; Park YS; Cho KH; Kim YH; Park SC
J Vet Pharmacol Ther; 2009 Jun; 32(3):219-28. PubMed ID: 19646085
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone pharmacodynamics and efficacy.
Doern GV; Tillotson GS
Chest; 2001 Jul; 120(1):319-20. PubMed ID: 11451862
[No Abstract] [Full Text] [Related]
12. Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa.
McNabb J; Quintiliani R; Nightingale CH; Nicolau DP
Chemotherapy; 2000; 46(6):383-9. PubMed ID: 11053903
[TBL] [Abstract][Full Text] [Related]
13. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
14. Penetration of ciprofloxacin into the mucosa of the human maxillary sinus.
Maier H; Zielinski D; Seigoleit A
J Chemother; 1989 Jul; 1(4 Suppl):570-1. PubMed ID: 16312536
[No Abstract] [Full Text] [Related]
15. Target site concentrations of ciprofloxacin after single intravenous and oral doses.
Brunner M; Stabeta H; Möller JG; Schrolnberger C; Erovic B; Hollenstein U; Zeitlinger M; Eichler HG; Müller M
Antimicrob Agents Chemother; 2002 Dec; 46(12):3724-30. PubMed ID: 12435668
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ciprofloxacin following intravenous and oral administration in broiler chickens.
Atta AH; Sharif L
J Vet Pharmacol Ther; 1997 Aug; 20(4):326-9. PubMed ID: 9280374
[No Abstract] [Full Text] [Related]
17. Comparative bioavailability of two oral formulations of ciprofloxacin.
Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
[No Abstract] [Full Text] [Related]
18. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
Washington C; Hou SY; Hughes NC; Campanella C; Berner B
J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
Khan MK; Khan MF
Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
Smirnova LB; Sokolova VI
Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
